Skip to main content

spontaneous autoimmune type 1 diabetes LEW.1AR1-IDDM rat

自发性自身免疫1型糖尿病。

Outcome measures

340 nm吸光度变化对应的葡萄糖浓度。

血糖浓度读数。

Experimental animals

血液葡萄糖浓度酶法测定
Tissue
blood glucose assay samples
大鼠尾静脉血糖测定
Tissue
rat tail-vein blood
大鼠尾静脉血糖测定
Tissue
rat tail-vein blood
大鼠尾静脉血糖测定
Tissue
rat tail-vein blood
大鼠尾静脉血糖测定
Tissue
rat tail-vein blood
大鼠尾静脉血糖测定
Tissue
rat tail-vein blood

Experimental procedures

Calibrate Cobas for Glucose analysis by running a multi analyte standard and two control serum. Calibrate Cobas for Glucose analysis by running a multi analyte standard and two control serum. Sample Handling as performed by the Cobas Mira Plus. Sample Handling as performed by the Cobas Mira Plus. a) Pipette 3 µL of sample into cuvette. b) Absorbance is measured at 340 nm. c) Add 100 µL of Glucose liquid reagent. d) Mixture is incubated at 37ºC for 10 minutes. e) Absorbance is measured at 340 nm. Change in absorbance is calculated.

**Measurement of Blood Glucose ** **Measurement of Blood Glucose ** Blood samples were collected from the tail vein for the determination of blood glucose levels using Accutrend Plus test strips and meter (Roche).

Model identity

Model name
spontaneous autoimmune type 1 diabetes LEW.1AR1-IDDM rat
Species
rat
Genetic background
Lewis

Biological characteristics

Research questions
自身免疫性糖尿病的发病与进展。

Experimental methods

Experimental protocols

Reagents and materials

References

  1. Future Perspective of Diabetic Animal Models. Endocrine, Metabolic & Immune Disorders Drug Targets. 2020
  2. Extraction identity record 67d3f4ff98efd988e94a257d215316617fea4a87e3c0ee030d761f581cf852de
  3. Future Perspective of Diabetic Animal Models. PMID:31241444
  4. protocols.io · vv1 · John Stack; Gary Cline · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
  5. protocols.io · vv2 · Michael Hill · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
  6. ARRIVE 2.0 guidelines